HD-OPM Archive
Hashtags

#chip

15 posts

Mutated blood stem cells (CHIP) may be a major cause of heart disease, doubling MI risk

Apr 08, 2024 · Louis Nervegna ♥ 14 · 💬 13 Inflammation & CRP

Louis explains clonal hematopoiesis (CHIP): age-related mutations in bone-marrow stem cells yield white blood cells that drive inflammation and plaque growth, and the same mutations link to leukemia. A quoted report says CHIP carriers had a 54% higher chance of dying within a decade, from heart attacks and strokes, and mouse transplants of CHIP-mutated cells produced fast-growing, inflamed plaques. Louis credits Gokhan Can for pointing him to this.

High vitamin B12 in a multivitamin did not raise disease risk in a 14-year Harvard trial

Oct 02, 2026 · Louis Nervegna ♥ 14 · 💬 9 Supplements & vitamins

The poster argues it is unlikely high B12 intake causes cancer or clonal disease. The Physicians' Health Study multivitamin trial, which contained 10 times the RDA of B12, found no increase in major disease over 14 years and an 8% lower overall cancer risk. Nurses' and Physicians' cohorts also found no B12-disease link, except combined B12 and B6 with hip fracture, which vanished for B12 alone.

EVITA trial: vitamin C lowered deaths in clonal blood conditions (exploratory result)

Sep 29, 2026 · Louis Nervegna ♥ 15 · 💬 8 Supplements & vitamins

In the small phase 2 EVITA randomized trial of oral vitamin C in clonal cytopenia and lower-risk myeloid cancers, the vitamin C group had 65% lower risk of death (11 vs 24 deaths) and fewer serious adverse events. Survival was exploratory and the primary endpoint of clonal growth showed no difference. The poster speculates relevance to CHIP and cardiovascular disease but calls it a big unproven leap.

Somatic mutations may set an upper bound on human lifespan

Jul 17, 2026 · Louis Nervegna ♥ 10 · 💬 6 Aging & longevity

Louis reposts a discussion of an npj Aging model suggesting irreversible somatic DNA mutations limit human lifespan. He notes that mutation accumulation contributes to heart disease (e.g., CHIP) and aging and that no known technology reverses them.

CHIP (clonal hematopoiesis): a little-known risk factor for heart disease and stroke

Apr 08, 2024 · Gokhan Can ♥ 5 · 💬 3 Risk assessment & lab tests

Explains clonal hematopoiesis of indeterminate potential: blood cells carrying acquired mutations that raise the risk of blood cancers, coronary disease and stroke. It becomes more common with age, can be detected with a next-generation sequencing panel, and has no specific treatment yet. The post notes testosterone therapy and anything strongly stimulating bone marrow may help CHIP expand.

CHIP not tied to heart attack or stroke in a 9,434-person aspirin trial, but to bleeding

Oct 18, 2025 · Louis Nervegna ♥ 1 · 💬 1 Aspirin, antiplatelets & blood thinners

Louis shares a JAMA Cardiology secondary analysis of a primary-prevention aspirin trial (9,434 participants) on clonal hematopoiesis of indeterminate potential (CHIP), a common aging-related blood cell mutation. CHIP was not associated with more cardiovascular events but was associated with more clinically significant bleeding, and aspirin's effects did not differ by CHIP status. He also explains what CHIP is.